Federal contract award
75A50325F80035
PURCHASE CIPROFLOXACIN 250MG/5ML ORAL SUSPENSION, POWDER, 100ML BOTTLE
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | ASPR/ORM-SNS |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | 36F79720D0237 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $15.1M |
| Current contract value | $15.1M |
| Potential contract value / ceiling | $15.1M |
| Start date | Sep 30, 2025 |
| Current end date | Sep 29, 2026 |
| Potential end date | Sep 29, 2026 |
| Latest award activity | Sep 26, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 26, 2025 | 0 | $15.1M | PURCHASE CIPROFLOXACIN 250MG/5ML ORAL SUSPENSION, POWDER, 100ML BOTTLE |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.